These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26216355)

  • 1. Prostate cancer: net survival and cause-specific survival rates after multiple imputation.
    Morisot A; Bessaoud F; Landais P; Rébillard X; Trétarre B; Daurès JP
    BMC Med Res Methodol; 2015 Jul; 15():54. PubMed ID: 26216355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
    Zhu X; Kranse R; Bul M; Bangma CH; Schröder FH; Roobol MJ
    Can J Urol; 2013 Jun; 20(3):6756-60. PubMed ID: 23783043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
    Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
    Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Beyer DC; McKeough T; Thomas T
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer.
    Morris WJ; Keyes M; Spadinger I; Kwan W; Liu M; McKenzie M; Pai H; Pickles T; Tyldesley S
    Cancer; 2013 Apr; 119(8):1537-46. PubMed ID: 23280183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
    Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
    Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correcting bias due to missing stage data in the non-parametric estimation of stage-specific net survival for colorectal cancer using multiple imputation.
    Falcaro M; Carpenter JR
    Cancer Epidemiol; 2017 Jun; 48():16-21. PubMed ID: 28315607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Adamovich E
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):669-77. PubMed ID: 16682149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up].
    Luján M; Páez Á; Berenguer A; Rodríguez JA
    Actas Urol Esp; 2012; 36(7):403-9. PubMed ID: 22269382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
    Loeb S; Zhu X; Schroder FH; Roobol MJ
    BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone levels and survival in screening-detected prostate cancer: a 15-yr follow-up study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    Eur Urol; 2008 Jan; 53(1):106-11. PubMed ID: 17482753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
    Mikel Hubanks J; Boorjian SA; Frank I; Gettman MT; Houston Thompson R; Rangel LJ; Bergstralh EJ; Jeffrey Karnes R
    Urol Oncol; 2014 Jan; 32(1):26.e1-7. PubMed ID: 23395235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.
    Wu JN; Fish KM; Evans CP; Devere White RW; Dall'Era MA
    Cancer; 2014 Mar; 120(6):818-23. PubMed ID: 24258693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.
    de Vries SH; Postma R; Raaijmakers R; Roemeling S; Otto S; de Koning HJ; Schröder FH
    Eur Urol; 2007 Feb; 51(2):366-74; discussion 374. PubMed ID: 16930812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].
    Sun B; Shao Y; Li J; Tian H; Li C
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):913-8. PubMed ID: 24854911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients undergoing radical prostatectomy have a better survival than the background population.
    Røder MA; Brasso K; Berg KD; Thomsen FB; Gruschy L; Rusch E; Iversen P
    Dan Med J; 2013 Apr; 60(4):A4612. PubMed ID: 23651719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer in the senior men from rural areas in east district of China: contemporary management and 5-year outcomes at multi-institutional collaboration.
    Shao Q; Ouyang J; Fan Y; Xie J; Zhou J; Wu J; Karim Kader A; Xu J; Liu G; Shan Y; Wen D; Zhang Y
    Cancer Lett; 2012 Feb; 315(2):170-7. PubMed ID: 22099876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary causes of death after permanent prostate brachytherapy.
    Bittner N; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Brammer SG; Moyad M
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):433-40. PubMed ID: 18448268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.